{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T13:50:06Z","timestamp":1792245006777,"version":"4.4.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T00:00:00Z","timestamp":1684540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014476","name":"Pfizer Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Diagnostic delay is high in acromegaly and leads to increased morbidity and mortality. The aim of this study is to systematically assess the most prevalent clinical signs, symptoms and comorbidities of acromegaly at time of diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A literature search (in PubMed, Embase and Web of Science) was performed on November 18, 2021, in collaboration with a medical information specialist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prevalence data on (presenting) clinical signs, symptoms and comorbidities at time of diagnosis were extracted and synthesized as weighted mean prevalence. The risk of bias was assessed for each included study using the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Risk of bias and heterogeneity was high in the 124 included articles. Clinical signs and symptoms with the highest weighted mean prevalence were: acral enlargement (90%), facial features (65%), oral changes (62%), headache (59%), fatigue\/tiredness (53%; including daytime sleepiness: 48%), hyperhidrosis (47%), snoring (46%), skin changes (including oily skin: 37% and thicker skin: 35%), weight gain (36%) and arthralgia (34%). Concerning comorbidities, acromegaly patients more frequently had hypertension, left ventricle hypertrophy, dia\/systolic dysfunction, cardiac arrhythmias, (pre)diabetes, dyslipidemia and intestinal polyps- and malignancy than age- and sex matched controls. Noteworthy, cardiovascular comorbidity was lower in more recent studies. Features that most often led to diagnosis of acromegaly were typical physical changes (acral enlargement, facial changes and prognatism), local tumor effects (headache and visual defect), diabetes, thyroid cancer and menstrual disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Acromegaly manifests itself with typical physical changes but also leads to a wide variety of common comorbidities, emphasizing that recognition of a combination of these features is key to establishing the diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11102-023-01322-7","type":"journal-article","created":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T16:22:59Z","timestamp":1684599779000},"page":"319-332","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["Prevalence of clinical signs, symptoms and comorbidities at diagnosis of acromegaly: a systematic review in accordance with PRISMA guidelines"],"prefix":"10.1007","volume":"26","author":[{"given":"Tessa N. A.","family":"Slagboom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa C.","family":"van Bunderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"De Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Bisschop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine L.","family":"Drent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"issue":"1","key":"1322_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12020-018-1764-4","volume":"63","author":"P Caron","year":"2019","unstructured":"Caron P, Brue T, Raverot G, Tabarin A, Cailleux A, Delemer B et al (2019) Signs and symptoms of acromegaly at diagnosis: the physician\u2019s and the patient\u2019s perspectives in the ACRO-POLIS study. Endocrine 63(1):120\u2013129","journal-title":"Endocrine"},{"issue":"1","key":"1322_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93(1):61\u201367","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1322_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1530\/EJE-20-0019","volume":"182","author":"D Esposito","year":"2020","unstructured":"Esposito D, Ragnarsson O, Johannsson G, Olsson DS (2020) Prolonged diagnostic delay in acromegaly is associated with increased morbidity and mortality. Eur J Endocrinol 182(6):523\u2013531","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"1322_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","volume":"20","author":"A Lavrentaki","year":"2017","unstructured":"Lavrentaki A, Paluzzi A, Wass JA, Karavitaki N (2017) Epidemiology of acromegaly: review of population studies. Pituitary 20(1):4\u20139","journal-title":"Pituitary"},{"issue":"4","key":"1322_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2265.1987.tb00805.x","volume":"26","author":"J Nabarro","year":"1987","unstructured":"Nabarro J (1987) Acromegaly. Clin Endocrinol 26(4):481\u2013512","journal-title":"Clin Endocrinol"},{"issue":"21","key":"1322_CR6","first-page":"1106","volume":"87","author":"DA Gordon","year":"1962","unstructured":"Gordon DA, Hill FM, Ezrin C (1962) Acromegaly: a review of 100 cases. Can Med Assoc J 87(21):1106\u20131109","journal-title":"Can Med Assoc J"},{"key":"1322_CR7","first-page":"53","volume":"8","author":"MH Gurel","year":"2014","unstructured":"Gurel MH, Bruening PR, Rhodes C, Lomax KG (2014) Patient perspectives on the impact of acromegaly: results from individual and group interviews. Patient Prefer Adherence 8:53\u201362","journal-title":"Patient Prefer Adherence"},{"issue":"3","key":"1322_CR8","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s11102-015-0702-1","volume":"19","author":"I Kreitschmann-Andermahr","year":"2016","unstructured":"Kreitschmann-Andermahr I, Siegel S, Kleist B, Kohlmann J, Starz D, Buslei R et al (2016) Diagnosis and management of acromegaly: the patient\u2019s perspective. Pituitary 19(3):268\u2013276","journal-title":"Pituitary"},{"issue":"2","key":"1322_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2265.2009.03626.x","volume":"72","author":"TJ Reid","year":"2010","unstructured":"Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72(2):203\u2013208","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1322_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1071\/HC15033","volume":"8","author":"R Zarool-Hassan","year":"2016","unstructured":"Zarool-Hassan R, Conaglen HM, Conaglen JV, Elston MS (2016) Symptoms and signs of acromegaly: an ongoing need to raise awareness among healthcare practitioners. J Prim Health Care 8(2):157\u2013163","journal-title":"J Prim Health Care"},{"issue":"3","key":"1322_CR11","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. PLoS Med 18(3):e1003583","journal-title":"PLoS Med"},{"issue":"10","key":"1322_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1530\/ERC-17-0253","volume":"24","author":"P Petrossians","year":"2017","unstructured":"Petrossians P, Daly AF, Natchev E, Maione L, Blijdorp K, Sahnoun-Fathallah M et al (2017) Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge acromegaly survey (LAS) database. Endocr Relat Cancer 24(10):505\u2013518","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"1322_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1097\/XEB.0000000000000054","volume":"13","author":"ZMS Munn","year":"2015","unstructured":"Munn ZMS, Lisy K, Riitano D, Tufanaru C (2015) Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and incidence data. Int J Evid Based Healthc 13(3):147\u2013153","journal-title":"Int J Evid Based Healthc"},{"key":"1322_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jclinepi.2020.06.039","volume":"127","author":"CB Migliavaca","year":"2020","unstructured":"Migliavaca CB, Stein C, Colpani V, Munn Z, Falavigna M (2020) Quality assessment of prevalence studies: a systematic review. J Clin Epidemiol 127:59\u201368","journal-title":"J Clin Epidemiol"},{"key":"1322_CR15","volume-title":"Biostatistics: A foundation for analysis in the health sciences","author":"W Daniel","year":"1999","unstructured":"Daniel W (1999) Biostatistics: A foundation for analysis in the health sciences, 7th edn. Wiley, New York","edition":"7"},{"issue":"1","key":"1322_CR16","first-page":"9","volume":"1","author":"LWT Naing","year":"2006","unstructured":"Naing LWT, Rusli BN (2006) Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci 1(1):9\u201314","journal-title":"Arch Orofac Sci"},{"issue":"3","key":"1322_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1440-1746.2003.03282.x","volume":"19","author":"A Bhansali","year":"2004","unstructured":"Bhansali A, Kochhar R, Chawla YK, Reddy S, Dash RJ (2004) Prevalence of colonic polyps is not increased in patients with acromegaly: analysis of 60 patients from India. J Gastroenterol Hepatol 19(3):266\u2013269","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"1322_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/0028-3886.158210","volume":"63","author":"P Dutta","year":"2015","unstructured":"Dutta P, Hajela A, Pathak A, Bhansali A, Radotra BD, Vashishta RK et al (2015) Clinical profile and outcome of patients with acromegaly according to the 2014 consensus guidelines: impact of a multi-disciplinary team. Neurol India 63(3):360\u2013368","journal-title":"Neurol India"},{"issue":"5","key":"1322_CR19","doi-asserted-by":"publisher","first-page":"594","DOI":"10.4158\/EP161724.OR","volume":"23","author":"B Gonzalez","year":"2017","unstructured":"Gonzalez B, Vargas G, Mendoza V, Nava M, Rojas M, Mercado M (2017) The prevalence of colonic polyps in patients with acromegaly: a case-control, nested in a cohort colonoscopic study. Endocr Pract 23(5):594\u2013599","journal-title":"Endocr Pract"},{"issue":"10","key":"1322_CR20","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.1210\/jc.2018-01113","volume":"103","author":"MAL de los Espinosa","year":"2018","unstructured":"de los Espinosa MAL, Sosa-Eroza E, Gonzalez B, Mendoza V, Mercado M (2018) Prevalence, clinical and biochemical spectrum, and treatment outcome of acromegaly with normal basal gh at diagnosis. J Clin Endocrinol Metab 103(10):3919\u20133924","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1322_CR21","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1210\/jc.2006-2551","volume":"92","author":"A Colao","year":"2007","unstructured":"Colao A, Pivonello R, Auriemma RS, Galdiero M, Ferone D, Minuto F et al (2007) The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients. J Clin Endocrinol Metab 92(10):3854\u20133860","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1322_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1530\/EJE-11-0408","volume":"165","author":"A Colao","year":"2011","unstructured":"Colao A, Pivonello R, Grasso LF, Auriemma RS, Galdiero M, Savastano S et al (2011) Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study. Eur J Endocrinol 165(5):713\u2013721","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"1322_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1055\/s-0032-1314811","volume":"121","author":"C Berg","year":"2013","unstructured":"Berg C, Petersenn S, Walensi M, M\u00f6hlenkamp S, Bauer M, Lehmann N et al (2013) Cardiac risk in patients with treatment na\u00efve, first-line medically controlled and first-line surgically cured acromegaly in comparison to matched data from the general population. Exp Clin Endocrinol Diabet 121(2):125\u2013132","journal-title":"Exp Clin Endocrinol Diabet"},{"issue":"8","key":"1322_CR24","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0002-9343(02)01094-X","volume":"112","author":"SS Damjanovic","year":"2002","unstructured":"Damjanovic SS, Neskovic AN, Petakov MS, Popovic V, Vujisic B, Petrovic M et al (2002) High output heart failure in patients with newly diagnosed acromegaly. Am J Med 112(8):610\u2013616","journal-title":"Am J Med"},{"issue":"2","key":"1322_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11102-013-0482-4","volume":"17","author":"M Dural","year":"2014","unstructured":"Dural M, Kabakc\u0131 G, C\u0131nar N, Erba\u015f T, Canpolat U, G\u00fcrses KM et al (2014) Assessment of cardiac autonomic functions by heart rate recovery, heart rate variability and QT dynamicity parameters in patients with acromegaly. Pituitary 17(2):163\u2013170","journal-title":"Pituitary"},{"key":"1322_CR26","doi-asserted-by":"publisher","first-page":"573643","DOI":"10.1155\/2015\/573643","volume":"2015","author":"X Guo","year":"2015","unstructured":"Guo X, Gao L, Zhang S, Li Y, Wu Y, Fang L et al (2015) Cardiovascular system changes and related risk factors in acromegaly patients: a case-control study. Int J Endocrinol 2015:573643","journal-title":"Int J Endocrinol"},{"issue":"17","key":"1322_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00508-018-1367-3","volume":"130","author":"R Iliaz","year":"2018","unstructured":"Iliaz R, Dogansen SC, Tanrikulu S, Yalin GY, Cavus B, Gulluoglu M et al (2018) Predictors of colonic pathologies in active acromegaly: single tertiary center experience. Wien Klin Wochenschr 130(17):511\u2013516","journal-title":"Wien Klin Wochenschr"},{"issue":"5","key":"1322_CR28","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1572-0241.2005.40808.x","volume":"100","author":"Y Matano","year":"2005","unstructured":"Matano Y, Okada T, Suzuki A, Yoneda T, Takeda Y, Mabuchi H (2005) Risk of colorectal neoplasm in patients with acromegaly and its relationship with serum growth hormone levels. Am J Gastroenterol 100(5):1154\u20131160","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1322_CR29","first-page":"227","volume":"71","author":"A Popielarz-Grygalewicz","year":"2020","unstructured":"Popielarz-Grygalewicz A, Stelmachowska-Bana\u015b M, G\u0105sior JS, Grygalewicz P, Czubalska M, Zgliczy\u0144ski W et al (2020) Subclinical left ventricular systolic dysfunction in patients with naive acromegaly - assessment with two-dimensional speckle-tracking echocardiography: retrospective study. Endokrynol Pol 71(3):227\u2013234","journal-title":"Endokrynol Pol"},{"issue":"6","key":"1322_CR30","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/01.mao.0000201429.57746.1b","volume":"27","author":"BB Babic","year":"2006","unstructured":"Babic BB, Petakov MS, Djukic VB, Ognjanovic SI, Arsovic NA, Isailovic TV et al (2006) Conductive hearing loss in patients with active acromegaly. Otol Neurotol 27(6):865\u2013870","journal-title":"Otol Neurotol"},{"issue":"3","key":"1322_CR31","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1210\/jc.2007-1197","volume":"93","author":"R Baldelli","year":"2008","unstructured":"Baldelli R, De Marinis L, Bianchi A, Pivonello R, Gasco V, Auriemma R et al (2008) Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor. J Clin Endocrinol Metab 93(3):710\u2013714","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1322_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/BF03346578","volume":"33","author":"F Bogazzi","year":"2010","unstructured":"Bogazzi F, Nacci A, Campomori A, La Vela R, Rossi G, Lombardi M et al (2010) Analysis of voice in patients with untreated active acromegaly. J Endocrinol Invest 33(3):178\u2013185","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"1322_CR33","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/BF03346334","volume":"30","author":"A Colao","year":"2007","unstructured":"Colao A, Pivonello R, Spinelli L, Galderisi M, Auriemma RS, Galdiero M et al (2007) A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients. J Endocrinol Invest 30(6):497\u2013506","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1322_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/EJE-16-0117","volume":"175","author":"J Dal","year":"2016","unstructured":"Dal J, Feldt-Rasmussen U, Andersen M, Kristensen L, Laurberg P, Pedersen L et al (2016) Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol 175(3):181\u2013190","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1322_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1530\/eje.0.1510309","volume":"151","author":"BL Herrmann","year":"2004","unstructured":"Herrmann BL, Wessendorf TE, Ajaj W, Kahlke S, Teschler H, Mann K (2004) Effects of octreotide on sleep apnoea and tongue volume (magnetic resonance imaging) in patients with acromegaly. Eur J Endocrinol 151(3):309\u2013315","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"1322_CR36","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1007\/s00198-015-3344-2","volume":"27","author":"AR Hong","year":"2016","unstructured":"Hong AR, Kim JH, Kim SW, Kim SY, Shin CS (2016) Trabecular bone score as a skeletal fragility index in acromegaly patients. Osteoporos Int 27(3):1123\u20131129","journal-title":"Osteoporos Int"},{"issue":"3","key":"1322_CR37","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1365-2265.2004.01985.x","volume":"60","author":"G Vitale","year":"2004","unstructured":"Vitale G, Galderisi M, Pivonello R, Spinelli L, Ciccarelli A, de Divitiis O et al (2004) Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass. Clin Endocrinol (Oxf) 60(3):343\u2013349","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1322_CR38","first-page":"704","volume":"5","author":"D Berker","year":"2010","unstructured":"Berker D, Tutuncu YA, Isik S, Aydin Y, Ozuguz U, Akbaba G et al (2010) Prevalence and recurrence rate of colonic lesions in acromegalic patients. Central Eur J Med 5(6):704\u2013711","journal-title":"Central Eur J Med"},{"issue":"3","key":"1322_CR39","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11102-014-0580-y","volume":"18","author":"M Yamamoto","year":"2015","unstructured":"Yamamoto M, Fukuoka H, Iguchi G, Matsumoto R, Takahashi M, Nishizawa H et al (2015) The prevalence and associated factors of colorectal neoplasms in acromegaly: a single center based study. Pituitary 18(3):343\u2013351","journal-title":"Pituitary"},{"issue":"1","key":"1322_CR40","first-page":"25","volume":"7","author":"A Al-Futaisi","year":"2007","unstructured":"Al-Futaisi A, Saif AY, Al-Zakwani I, Al-Qassabi S, Al-Riyami S, Wali Y (2007) Clinical and epidemiological characteristics of pituitary tumours using a web-based pituitary tumour registry in Oman. Sultan Qaboos Univ Med J 7(1):25\u201330","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"17","key":"1322_CR41","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.3390\/jcm10173997","volume":"10","author":"J Szyde\u0142ko","year":"2021","unstructured":"Szyde\u0142ko J, Szyde\u0142ko-Gorzkowicz M, Matyjaszek-Matuszek B (2021) Neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios, and systemic immune-inflammation index as potential biomarkers of chronic inflammation in patients with newly diagnosed acromegaly: a single-centre study. J Clin Med 10(17):3997","journal-title":"J Clin Med"},{"key":"1322_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fendo.2020.00429","volume":"11","author":"X Yan","year":"2020","unstructured":"Yan X, Chen X, Ge H, Zhu S, Lin Y, Kang D et al (2020) The change in distance between bilateral internal carotid arteries in acromegaly and its risk factors. Front Endocrinol (Lausanne) 11:429","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"1322_CR43","first-page":"224","volume":"21","author":"G Akoglu","year":"2013","unstructured":"Akoglu G, Metin A, Emre S, Ersoy R, Cakir B (2013) Cutaneous findings in patients with acromegaly. Acta Dermatovenerol Croat 21(4):224\u2013229","journal-title":"Acta Dermatovenerol Croat"},{"issue":"2","key":"1322_CR44","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ando.2018.08.006","volume":"80","author":"F Albarel","year":"2019","unstructured":"Albarel F, Elaraki F, Delemer B (2019) Daily life, needs and expectations of patients with acromegaly in France: An on-line survey. Ann Endocrinol (Paris) 80(2):110\u2013116","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"1322_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11102-013-0472-6","volume":"17","author":"I Fukuda","year":"2014","unstructured":"Fukuda I, Hizuka N, Muraoka T, Kurimoto M, Yamakado Y, Takano K et al (2014) Clinical features and therapeutic outcomes of acromegaly during the recent 10 years in a single institution in Japan. Pituitary 17(1):90\u201395","journal-title":"Pituitary"},{"issue":"2","key":"1322_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1136\/jim-2020-001605","volume":"69","author":"EA Giraldi","year":"2021","unstructured":"Giraldi EA, Veledar E, Oyesiku NM, Ioachimescu AG (2021) Incidentally detected acromegaly: single-center study of surgically treated patients over 22 years. J Investig Med 69(2):351\u2013357","journal-title":"J Investig Med"},{"key":"1322_CR47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s12020-019-02123-4","volume":"67","author":"AG Ioachimescu","year":"2020","unstructured":"Ioachimescu AG, Handa T, Goswami N, Pappy AL, Veledar E, Oyesiku NM (2020) Gender differences and temporal trends over two decades in acromegaly: a single center study in 112 patients. Endocrine 67:423\u2013432","journal-title":"Endocrine"},{"key":"1322_CR48","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2021.40.31.29920","author":"P Ganokroj","year":"2021","unstructured":"Ganokroj P, Sunthornyothin S, Siwanuwatn R, Chantra K, Buranasupkajorn P, Suwanwalaikorn S et al (2021) Clinical characteristics and treatment outcomes in acromegaly, a retrospective single-center case series from thailand. Pan Afr Med J. https:\/\/doi.org\/10.11604\/pamj.2021.40.31.29920","journal-title":"Pan Afr Med J"},{"issue":"17","key":"1322_CR49","first-page":"617","volume":"61","author":"I Jialal","year":"1982","unstructured":"Jialal I, Nathoo BC, Joubert S, Asmal AC, Pillay NL (1982) The clinical presentation and biochemical diagnosis of acromegaly and gigantism. S Afr Med J 61(17):617\u2013620","journal-title":"S Afr Med J"},{"issue":"6","key":"1322_CR50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40618-015-0245-3","volume":"38","author":"FE Keskin","year":"2015","unstructured":"Keskin FE, Yetkin DO, Ozkaya HM, Haliloglu O, Sadri S, Gazioglu N et al (2015) The problem of unrecognized acromegaly: surgeries patients undergo prior to diagnosis of acromegaly. J Endocrinol Invest 38(6):695\u2013700","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"1322_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1530\/acta.0.0950289","volume":"95","author":"JGM Klijn","year":"1980","unstructured":"Klijn JGM, Lamberts SWJ, de Jong FH, van Dongen KJ, Birkenh\u00e4ger JC (1980) Interrelationships between tumour size, age, plasma growth hormone and incidence of extrasellar extension in acromegalic patients. Eur J Endocrinol 95(3):289\u2013297","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"1322_CR52","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1210\/jc.2007-2149","volume":"93","author":"L Nachtigall","year":"2008","unstructured":"Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A (2008) Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 93(6):2035\u20132041","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1322_CR53","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11102-012-0447-z","volume":"16","author":"S Siegel","year":"2013","unstructured":"Siegel S, Streetz van der Werf C, Schott JS, Nolte K, Karges W, Kreitschmann-Andermahr I (2013) Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary 16(4):507\u2013514","journal-title":"Pituitary"},{"issue":"1","key":"1322_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s42000-020-00235-5","volume":"20","author":"F Ceccato","year":"2021","unstructured":"Ceccato F, Barbot M, Lizzul L, Cuccarollo A, Selmin E, Merante Boschin I et al (2021) Clinical presentation and management of acromegaly in elderly patients. Hormones 20(1):143\u2013150","journal-title":"Hormones"},{"issue":"42","key":"1322_CR55","first-page":"1431","volume":"116","author":"B Giorgis","year":"1986","unstructured":"Giorgis B, Campiche R, Burckhardt P, G\u00f3mez F (1986) Diagnosis, treatment and course of hypophyseal tumors. Retrospective study of 123 cases. Schweiz Med Wochenschr 116(42):1431\u20131440","journal-title":"Schweiz Med Wochenschr"},{"issue":"10","key":"1322_CR56","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jfma.2018.12.017","volume":"118","author":"FY Tseng","year":"2019","unstructured":"Tseng FY, Huang TS, Lin JD, Chen ST, Wang PW, Chen JF et al (2019) A registry of acromegaly patients and one year following up in Taiwan. J Formos Med Assoc 118(10):1430\u20131437","journal-title":"J Formos Med Assoc"},{"issue":"9","key":"1322_CR57","first-page":"514","volume":"3","author":"C Cuspidi","year":"2002","unstructured":"Cuspidi C, Michey I, Meani S, Severgnini B, Fusi V, Salerno M et al (2002) Trends in hypertension control and left ventricular hypertrophy over three years. Ital Heart J 3(9):514\u2013519","journal-title":"Ital Heart J"},{"issue":"20","key":"1322_CR58","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1001\/jama.2010.650","volume":"303","author":"BM Egan","year":"2010","unstructured":"Egan BM, Zhao Y, Axon RN (2010) US trends in prevalence, awareness, treatment, and control of hypertension, 1988\u20132008. JAMA 303(20):2043\u20132050","journal-title":"JAMA"},{"issue":"3","key":"1322_CR59","first-page":"178","volume":"63","author":"KR Arya","year":"1997","unstructured":"Arya KR, Krishna K, Chadda M (1997) Skin manifestations of acromegaly - a study of 34 cases. Indian J Dermatol Venereol Leprol 63(3):178\u2013180","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"3","key":"1322_CR60","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4103\/1793-5482.145354","volume":"11","author":"D Banerji","year":"2016","unstructured":"Banerji D, Das NK, Sharma S, Jindal Y, Jain VK, Behari S (2016) Surgical management of acromegaly: long term functional outcome analysis and assessment of recurrent\/residual disease. Asian J Neurosurg 11(3):261\u2013267","journal-title":"Asian J Neurosurg"},{"issue":"3","key":"1322_CR61","first-page":"e13852","volume":"13","author":"SA Khan","year":"2021","unstructured":"Khan SA, Ram N, Masood MQ (2021) Patterns of abnormal glucose metabolism in acromegaly and impact of treatment modalities on glucose metabolism. Cureus 13(3):e13852","journal-title":"Cureus"},{"issue":"5","key":"1322_CR62","doi-asserted-by":"publisher","first-page":"e172","DOI":"10.5001\/omj.2020.114","volume":"35","author":"K Al Dahmani","year":"2020","unstructured":"Al Dahmani K, Afandi B, Elhouni A, Dinwal D, Philip J et al (2020) Clinical presentation, treatment, and outcome of acromegaly in the United Arab Emirates. Oman Med J 35(5):e172","journal-title":"Oman Med J"},{"issue":"3","key":"1322_CR63","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s42000-020-00191-0","volume":"19","author":"MH AlMalki","year":"2020","unstructured":"AlMalki MH, Ahmad MM, Buhary BM, Aljawair R, Alyamani A, Alhozali A et al (2020) Clinical features and therapeutic outcomes of patients with acromegaly in Saudi Arabia: a retrospective analysis. Hormones (Athens) 19(3):377\u2013383","journal-title":"Hormones (Athens)"},{"issue":"8","key":"1322_CR64","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1742-1241.2011.02682.x","volume":"65","author":"P Anagnostis","year":"2011","unstructured":"Anagnostis P, Efstathiadou ZA, Polyzos SA, Adamidou F, Slavakis A, Sapranidis M et al (2011) Acromegaly: presentation, morbidity and treatment outcomes at a single centre. Int J Clin Pract 65(8):896\u2013902","journal-title":"Int J Clin Pract"},{"issue":"11","key":"1322_CR65","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1210\/jc.2016-1937","volume":"101","author":"LA Portocarrero-Ortiz","year":"2016","unstructured":"Portocarrero-Ortiz LA, Vergara-Lopez A, Vidrio-Velazquez M, Uribe-Diaz AM, Garc\u00eda-Dominguez A, Reza-Albarr\u00e1n AA et al (2016) The Mexican acromegaly registry: clinical and biochemical characteristics at diagnosis and therapeutic outcomes. J Clin Endocrinol Metab 101(11):3997\u20134004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1322_CR66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF02739824","volume":"10","author":"D Voit","year":"1999","unstructured":"Voit D, Saeger W, L\u00fcdecke DK (1999) Pituitary adenomas in acromegaly: comparison of different adenoma types with clinical data. Endocr Pathol 10(2):123\u2013135","journal-title":"Endocr Pathol"},{"issue":"4","key":"1322_CR67","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10194-010-0217-0","volume":"11","author":"LJ Stovner","year":"2010","unstructured":"Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289\u2013299","journal-title":"J Headache Pain"},{"issue":"3","key":"1322_CR68","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1468-2982.2007.01288.x","volume":"27","author":"L Stovner","year":"2007","unstructured":"Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A et al (2007) The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27(3):193\u2013210","journal-title":"Cephalalgia"},{"issue":"1","key":"1322_CR69","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000351292","volume":"227","author":"M Augustin","year":"2013","unstructured":"Augustin M, Radtke M, Herberger K, Kornek T, Heigel H, Schaefer I (2013) Prevalence and disease burden of hyperhidrosis in the adult population. Dermatology 227(1):10\u201313","journal-title":"Dermatology"},{"issue":"9","key":"1322_CR70","doi-asserted-by":"publisher","first-page":"e0220664","DOI":"10.1371\/journal.pone.0220664","volume":"14","author":"SMM Ribeiro","year":"2019","unstructured":"Ribeiro SMM, Betanho MR, Lopes RAC, Guimar\u00e3es RLP, dos Santos CB, Junior JCBS (2019) Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro. PLoS ONE 14(9):e0220664","journal-title":"PLoS ONE"},{"issue":"4","key":"1322_CR71","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1034\/j.1601-0825.2003.02933.x","volume":"9","author":"N Avcu","year":"2003","unstructured":"Avcu N, Kanli A (2003) The prevalence of tongue lesions in 5150 Turkish dental outpatients. Oral Dis 9(4):188\u2013195","journal-title":"Oral Dis"},{"issue":"3","key":"1322_CR72","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.4317\/jced.51102","volume":"5","author":"S Patil","year":"2013","unstructured":"Patil S, Kaswan S, Rahman F, Doni B (2013) Prevalence of tongue lesions in the Indian population. J Clin Exp Dent 5(3):e128","journal-title":"J Clin Exp Dent"},{"issue":"3","key":"1322_CR73","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/eurpub\/ckp113","volume":"20","author":"M Van\u2019t Leven","year":"2010","unstructured":"Van\u2019t Leven M, Zielhuis GA, van der Meer JW, Verbeek AL, Bleijenberg G (2010) Fatigue and chronic fatigue syndrome-like complaints in the general population. Eur J Public Health 20(3):251\u2013257","journal-title":"Eur J Public Health"},{"issue":"2","key":"1322_CR74","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1136\/jech.46.2.92","volume":"46","author":"G Lewis","year":"1992","unstructured":"Lewis G, Wessely S (1992) The epidemiology of fatigue: more questions than answers. J Epidemiol Community Health 46(2):92\u201397","journal-title":"J Epidemiol Community Health"},{"issue":"10","key":"1322_CR75","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/clc.22737","volume":"40","author":"MY van der Ende","year":"2017","unstructured":"van der Ende MY, Siland JE, Snieder H, van der Harst P, Rienstra M (2017) Population-based values and abnormalities of the electrocardiogram in the general Dutch population: the lifelines cohort study. Clin Cardiol 40(10):865\u2013872","journal-title":"Clin Cardiol"},{"issue":"1","key":"1322_CR76","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12872-022-02541-9","volume":"22","author":"Y Liu","year":"2022","unstructured":"Liu Y, Xu K, Wu S, Qin M, Liu X (2022) Value of estimated pulse wave velocity to identify left ventricular hypertrophy prevalence: insights from a general population. BMC Cardiovasc Disord 22(1):157","journal-title":"BMC Cardiovasc Disord"},{"issue":"1 Pt 2","key":"1322_CR77","first-page":"I26","volume":"75","author":"DD Savage","year":"1987","unstructured":"Savage DD, Garrison R, Kannel W, Levy D, Anderson S, Jr Stokes J et al (1987) The spectrum of left ventricular hypertrophy in a general population sample: the Framingham Study. Circulation 75(1 Pt 2):I26-33","journal-title":"Circulation"},{"issue":"2","key":"1322_CR78","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jama.289.2.194","volume":"289","author":"MM Redfield","year":"2003","unstructured":"Redfield MM, Jacobsen SJ, Burnett JC, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289(2):194\u2013202","journal-title":"JAMA"},{"issue":"5","key":"1322_CR79","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jacc.2013.10.063","volume":"63","author":"S-H Wan","year":"2014","unstructured":"Wan S-H, Vogel MW, Chen HH (2014) Pre-clinical diastolic dysfunction. J Am Coll Cardiol 63(5):407\u2013416","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1322_CR80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/00004872-200401000-00003","volume":"22","author":"PM Kearney","year":"2004","unstructured":"Kearney PM, Whelton M, Reynolds K, Whelton PK, He J (2004) Worldwide prevalence of hypertension: a systematic review. J Hypertens 22(1):11\u201319","journal-title":"J Hypertens"},{"issue":"1","key":"1322_CR81","doi-asserted-by":"publisher","first-page":"e001436","DOI":"10.1136\/bmjdrc-2020-001436","volume":"8","author":"SK van Zon","year":"2020","unstructured":"van Zon SK, Amick BC III, de Jong T, Brouwer S, B\u00fcltmann U (2020) Occupational distribution of metabolic syndrome prevalence and incidence differs by sex and is not explained by age and health behavior: results from 75 000 Dutch workers from 40 occupational groups. BMJ Open Diabet Res Care 8(1):e001436","journal-title":"BMJ Open Diabet Res Care"},{"issue":"1","key":"1322_CR82","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0168-8227(03)00066-4","volume":"61","author":"F Azizi","year":"2003","unstructured":"Azizi F, Salehi P, Etemadi A, Zahedi-Asl S (2003) Prevalence of metabolic syndrome in an urban population: Tehran lipid and glucose study. Diabetes Res Clin Pract 61(1):29\u201337","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"1322_CR83","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1017\/S1368980010003320","volume":"14","author":"F M\u00e1rquez-Sandoval","year":"2011","unstructured":"M\u00e1rquez-Sandoval F, Macedo-Ojeda G, Viramontes-H\u00f6rner D, Fern\u00e1ndez Ballart JD, Salas Salvad\u00f3 J, Vizmanos B (2011) The prevalence of metabolic syndrome in Latin America: a systematic review. Public Health Nutr 14(10):1702\u20131713","journal-title":"Public Health Nutr"},{"issue":"12","key":"1322_CR84","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1017\/S1368980008003492","volume":"11","author":"G Buckland","year":"2008","unstructured":"Buckland G, Salas-Salvad\u00f3 J, Roure E, Bull\u00f3 M, Serra-Majem L (2008) Sociodemographic risk factors associated with metabolic syndrome in a Mediterranean population. Public Health Nutr 11(12):1372\u20131378","journal-title":"Public Health Nutr"},{"issue":"2","key":"1322_CR85","doi-asserted-by":"publisher","first-page":"e0171502","DOI":"10.1371\/journal.pone.0171502","volume":"12","author":"EH van den Berg","year":"2017","unstructured":"van den Berg EH, Amini M, Schreuder TC, Dullaart RP, Faber KN, Alizadeh BZ et al (2017) Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: a large Dutch population cohort. PLoS ONE 12(2):e0171502","journal-title":"PLoS ONE"},{"issue":"1","key":"1322_CR86","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64(1):73\u201384","journal-title":"Hepatology"},{"issue":"1","key":"1322_CR87","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","volume":"10","author":"MAB Khan","year":"2020","unstructured":"Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al KJ (2020) Epidemiology of type 2 diabetes\u2013global burden of disease and forecasted trends. J Epidemiol Global Health 10(1):107","journal-title":"J Epidemiol Global Health"},{"issue":"1\u20132","key":"1322_CR88","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/s0304-3959(02)00372-x","volume":"102","author":"H Picavet","year":"2003","unstructured":"Picavet H, Schouten J (2003) Musculoskeletal pain in the Netherlands: prevalences, consequences and risk groups, the DMC3-study. Pain 102(1\u20132):167\u2013178","journal-title":"Pain"},{"issue":"2","key":"1322_CR89","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.berh.2010.01.012","volume":"25","author":"MA Cimmino","year":"2011","unstructured":"Cimmino MA, Ferrone C, Cutolo M (2011) Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 25(2):173\u2013183","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1322_CR90","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.sleep.2016.09.015","volume":"30","author":"GA Kerkhof","year":"2017","unstructured":"Kerkhof GA (2017) Epidemiology of sleep and sleep disorders in The Netherlands. Sleep Med 30:229\u2013239","journal-title":"Sleep Med"},{"key":"1322_CR91","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.smrv.2016.07.002","volume":"34","author":"CV Senaratna","year":"2017","unstructured":"Senaratna CV, Perret JL, Lodge CJ, Lowe AJ, Campbell BE, Matheson MC et al (2017) Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev 34:70\u201381","journal-title":"Sleep Med Rev"},{"issue":"3","key":"1322_CR92","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.cgh.2020.10.048","volume":"20","author":"FE Vuik","year":"2020","unstructured":"Vuik FE, Nieuwenburg SA, Moen S, Schreuders EH, Pool MDO, Peterse EF et al (2020) Population-based prevalence of gastrointestinal abnormalities at colon capsule endoscopy. Clin Gastroenterol Hepatol 20(3):692\u2013700","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1322_CR93","doi-asserted-by":"publisher","first-page":"6974","DOI":"10.1038\/s41598-020-63827-6","volume":"10","author":"J Pan","year":"2020","unstructured":"Pan J, Cen L, Xu L, Miao M, Li Y, Yu C et al (2020) Prevalence and risk factors for colorectal polyps in a Chinese population: a retrospective study. Sci Rep 10(1):6974","journal-title":"Sci Rep"},{"issue":"2","key":"1322_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15226\/2374-815X\/3\/2\/00156","volume":"3","author":"R Jayadevan","year":"2016","unstructured":"Jayadevan R, Anithadevi T, Venugopalan S (2016) Prevalence of colorectal polyps: a retrospective study to determine the cut-off age for screening. Gastroenterol Pancreatol Liver Disord 3(2):1\u20135","journal-title":"Gastroenterol Pancreatol Liver Disord"},{"issue":"75","key":"1322_CR95","first-page":"171","volume":"2","author":"J Gonz\u00e1lez-Gonz\u00e1lez","year":"2010","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez J, Maldonado-Garza H, Flores-Rend\u00f3n R, Garza-Galindo A (2010) Risk factors for colorectal polyps in a Mexican population [Corrected and republished]. Rev Gastroenterol Mex 2(75):171\u2013176","journal-title":"Rev Gastroenterol Mex"},{"issue":"7","key":"1322_CR96","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1001\/jamainternmed.2016.0960","volume":"176","author":"M Bretthauer","year":"2016","unstructured":"Bretthauer M, Kaminski MF, L\u00f8berg M, Zauber AG, Regula J, Kuipers EJ et al (2016) Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial. JAMA Intern Med 176(7):894\u2013902","journal-title":"JAMA Intern Med"},{"issue":"6","key":"1322_CR97","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3109\/02841861003733713","volume":"49","author":"V Lemmens","year":"2010","unstructured":"Lemmens V, Steenbergen LV, Janssen-Heijnen M, Martijn H, Rutten H, Coebergh JW (2010) Trends in colorectal cancer in the south of the Netherlands 1975\u20132007: rectal cancer survival levels with colon cancer survival. Acta Oncol 49(6):784\u2013796","journal-title":"Acta Oncol"},{"issue":"3","key":"1322_CR98","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.cgh.2019.07.016","volume":"18","author":"MCS Wong","year":"2020","unstructured":"Wong MCS, Huang J, Huang JLW, Pang TWY, Choi P, Wang J et al (2020) Global prevalence of colorectal neoplasia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 18(3):553\u201361.e10","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"1322_CR99","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00198-006-0206-y","volume":"18","author":"B H\u00e4ussler","year":"2007","unstructured":"H\u00e4ussler B, Gothe H, G\u00f6l D, Glaeske G, Pientka L, Felsenberg D (2007) Epidemiology, treatment and costs of osteoporosis in Germany\u2014the BoneEVA Study. Osteoporos Int 18(1):77\u201384","journal-title":"Osteoporos Int"},{"issue":"1","key":"1322_CR100","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","volume":"16","author":"N Salari","year":"2021","unstructured":"Salari N, Ghasemi H, Mohammadi L, Behzadi Mh, Rabieenia E, Shohaimi S et al (2021) The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis. J Orthop Surg Res 16(1):609","journal-title":"J Orthop Surg Res"},{"issue":"11","key":"1322_CR101","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1089\/thy.2004.14.926","volume":"14","author":"C Reiners","year":"2004","unstructured":"Reiners C, Wegscheider K, Schicha H, Theissen P, Vaupel R, Wrbitzky R et al (2004) Prevalence of thyroid disorders in the working population of Germany: ultrasonography screening in 96,278 unselected employees. Thyroid 14(11):926\u2013932","journal-title":"Thyroid"},{"key":"1322_CR102","doi-asserted-by":"publisher","first-page":"1029926","DOI":"10.3389\/fonc.2022.1029926","volume":"12","author":"C Mu","year":"2022","unstructured":"Mu C, Ming X, Tian Y, Liu Y, Yao M, Ni Y et al (2022) Mapping global epidemiology of thyroid nodules among general population: a systematic review and meta-analysis. Front Oncol 12:1029926","journal-title":"Front Oncol"},{"key":"1322_CR103","unstructured":"Nederlandse Kanker Registratie (NKR) Cijfers. [cited 2022 July 27th]. Available from: https:\/\/nkrcijfers.iknl.nl\/#\/viewer\/fac1d6c3-d784-498f-9838-8244804d5023"},{"issue":"1","key":"1322_CR104","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2015.10.003","volume":"370","author":"R Zheng","year":"2016","unstructured":"Zheng R, Zeng H, Zhang S, Chen T, Chen W (2016) National estimates of cancer prevalence in China, 2011. Cancer Lett 370(1):33\u201338","journal-title":"Cancer Lett"},{"issue":"22","key":"1322_CR105","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1056\/NEJM198611273152206","volume":"315","author":"AR Feldman","year":"1986","unstructured":"Feldman AR, Kessler L, Myers MH, Naughton MD (1986) The prevalence of cancer. N Engl J Med 315(22):1394\u20131397","journal-title":"N Engl J Med"},{"key":"1322_CR106","unstructured":"Trimbos-instituut. [cited 2022 July 27th]. Available from: https:\/\/www.trimbos.nl\/kennis\/cijfers\/depressie\/."},{"issue":"1","key":"1322_CR107","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/s41598-018-21243-x","volume":"8","author":"GY Lim","year":"2018","unstructured":"Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC (2018) Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep 8(1):2861","journal-title":"Sci Rep"},{"issue":"5","key":"1322_CR108","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1111\/bjd.16248","volume":"178","author":"A Svensson","year":"2018","unstructured":"Svensson A, Ofenloch R, Bruze M, Naldi L, Cazzaniga S, Elsner P et al (2018) Prevalence of skin disease in a population-based sample of adults from five European countries. Br J Dermatol 178(5):1111\u20131118","journal-title":"Br J Dermatol"},{"issue":"9859","key":"1322_CR109","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","volume":"380","author":"T Vos","year":"2012","unstructured":"Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990\u20132010: a systematic analysis for the global burden of disease study 2010. The Lancet 380(9859):2163\u20132196","journal-title":"The Lancet"},{"issue":"2","key":"1322_CR110","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.282.2.153","volume":"282","author":"I Atroshi","year":"1999","unstructured":"Atroshi I, Gummesson C, Johnsson R, Ornstein E, Ranstam J, Ros\u00e9n I (1999) Prevalence of carpal tunnel syndrome in a general population. JAMA 282(2):153\u2013158","journal-title":"JAMA"},{"issue":"03","key":"1322_CR111","first-page":"320","volume":"25","author":"S Hashimoto","year":"2020","unstructured":"Hashimoto S, Ikegami S, Nishimura H, Uchiyama S, Takahashi J, Kato H (2020) Prevalence and risk factors of carpal tunnel syndrome in Japanese aged 50 to 89 years. J Hand Surg 25(03):320\u2013327","journal-title":"J Hand Surg"},{"issue":"1","key":"1322_CR112","doi-asserted-by":"publisher","first-page":"13","DOI":"10.11648\/j.ejcbs.20170301.13","volume":"3","author":"KR Habib","year":"2017","unstructured":"Habib KR (2017) Estimation of carpal tunnel syndrome (CTS) prevalence in adult population in western European countries: a systematic review. Eur J Clin Biomed Sci 3(1):13\u201318","journal-title":"Eur J Clin Biomed Sci"},{"issue":"6","key":"1322_CR113","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.jvoice.2018.07.007","volume":"33","author":"V Lyberg-\u00c5hlander","year":"2019","unstructured":"Lyberg-\u00c5hlander V, Rydell R, Fredlund P, Magnusson C, Wil\u00e9n S (2019) Prevalence of voice disorders in the general population, based on the Stockholm public health cohort. J Voice 33(6):900\u2013905","journal-title":"J Voice"},{"issue":"10","key":"1322_CR114","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s00405-014-3252-7","volume":"272","author":"PL de Ara\u00fajo","year":"2015","unstructured":"de Ara\u00fajo PL, Espelt A, Balata PMM, de Lima KC (2015) Prevalence of voice disorders in the elderly: a systematic review of population-based studies. Eur Arch Otorhinolaryngol 272(10):2601\u20132609","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-023-01322-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-023-01322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T04:14:12Z","timestamp":1690949652000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-023-01322-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,20]]},"references-count":114,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1007\/s11102-023-01322-7","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,20]]},"assertion":[{"value":"26 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}